<DOC>
	<DOCNO>NCT03100136</DOCNO>
	<brief_summary>This study measure bind kinetics test-retest characteristic subpharmacological dose [ 11C ] PF-06809247 Monoacylglycerol lipase ( MAGL ) Positron Emission Tomography ( PET ) tracer healthy adult subject .</brief_summary>
	<brief_title>Test Re-Test Reliability 11CPF-06809247 Novel PET Tacer</brief_title>
	<detailed_description />
	<criteria>Healthy male subject , time screening , age 18 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease A confirm positive urine drug test . History regular alcohol consumption exceed 14 drinks/week ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month screen . Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day 2 chew tobacco per day . Screening supine blood pressure great equal than140 mm Hg ( systolic ) 90 mm Hg ( diastolic ) , follow least 5 minute supine rest . If blood . Screening supine 12lead ECG demonstrate QTc &gt; 450 msec QRS interval &gt; 120 msec . Subjects abnormalities clinical laboratory test screen , assess studyspecific laboratory confirm single repeat , deem necessary . Use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose study treatment . Herbal supplement must discontinue least 28 day prior first dose investigational product . Blood donation ( exclude plasma donation ) approximately 1 pint ( 500 mL ) within 56 day prior dose . History sensitivity heparin heparininduced thrombocytopenia . Unwilling unable comply Lifestyle Requirements describe protocol . Subjects severe claustrophobia impact ability perform baseline MRI PET scan . Fulfillment MRI contraindication standard radiography screening questionnaire ( metal implant , device , paramagnetic object contain within body excessive metalcontaining tattoo ) . Any person unable lie still within environment MRI PET scanner require period acquire image . Subjects anatomical abnormality head would either preclude tend confound analysis study data , include clinically significant abnormal finding MRI head . Subjects history prior radiation exposure research purpose ( eg , xray , computer tomography scan , PET research study ( y ) ) within past year Subjects insufficient arterial patency determine Allen 's test . Any condition possibly affect placement intravenous drug administration line , poor vein rating per PCRU procedure . History sensitivity local anesthetic likely use placement arterial line . History human immunodeficiency virus ( HIV ) , hepatitis B C ; positive testing HIV , hepatitis B surface antigen ( HepBsAg ) , hepatitis B core antibody ( HepBcAb ) hepatitis C antibody ( HCVAb ) . Male subject unwilling unable use highly effective method contraception outline protocol duration study least 28 day last dose investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PET</keyword>
	<keyword>[ 11C ] PF-06809247</keyword>
	<keyword>Reliability</keyword>
	<keyword>Scan , Safety</keyword>
</DOC>